Yu-Shin Hsu holds an MSc in Drug Discovery and Pharma Management from UCL. She previously worked as a hospital pharmacist in Taiwan before joining Beacon. She possesses clinical experience across a broad range of non-oncology and oncology therapies and has applied her medical knowledge in research at Hanson Wade. As the research analyst for the ADC module at Beacon Targeted Therapies, Yu-Shin provides insights into ADC drug development and emerging trends in the field, drawing from her extensive background in Clinical Pharmacy and Pharmaceutical Science.